Investigation of the Effect of Krill Oil on Sortilin in Liver and Adipose Tissue in Obese Rats


ATAK M., Sahin A. B., YILMAZ KUTLU E., KILIÇ H., Uydu H. A., SEVİM NALKIRAN H., ...Daha Fazla

MOLECULAR NUTRITION & FOOD RESEARCH, 2025 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1002/mnfr.70233
  • Dergi Adı: MOLECULAR NUTRITION & FOOD RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, Chemical Abstracts Core, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Sortilin regulates lipid metabolism, adipogenesis, and inflammation in obesity. While the anti-inflammatory and lipid-modulating effects of krill oil (KO) on obesity are well known, its effects on sortilin remain insufficiently investigated. This study investigates the potential effects of KO supplementation on sortilin and pro-inflammatory cytokine levels in rats fed a high-fat diet (HFD).Twenty-four male Sprague Dawley rats were randomly assigned to three groups: standard diet (SD), HFD, and HFD + KO (600 mg/kg/day KO via oral gavage for 12 weeks). Body weights were monitored weekly. Serum total cholesterol (TC), triglyceride, glucose, insulin, and HOMA-IR were measured. Sortilin, TNF-alpha, IL-1 beta, and IL-6 levels were assessed in liver and retroperitoneal (RP) adipose tissues. The HFD group showed significant increases in weight, TC, glucose, and HOMA-IR, with decreased hepatic and increased RP adipose sortilin and TNF-alpha levels. KO reduced serum TC, increased hepatic sortilin and TNF-alpha, and decreased their levels in RP adipose tissue. These findings indicate that KO exerts a protective effect against HFD-induced obesity and inflammation by modulating lipid metabolism, reducing TNF-alpha and sortilin levels. Therefore, KO may serve as a promising dietary intervention for mitigating obesity-related metabolic and inflammatory complications.